Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

BriaCell Therapeutics submits phase I/II protocol to the FDA

March 13, 2015

University of Toronto divulges new anti-Frizzled antibodies

March 12, 2015

FDA approves Unituxin for pediatric patients with high-risk neuroblastoma

March 11, 2015

Madison Vaccines confirms program expansions for prostate cancer vaccines

March 11, 2015

Heat Biologics receives FDA fast track designation for HS-410 in combination with BCG

March 10, 2015

arGEN-X exercises option to license antibody candidate for cancer immunotherapy

March 6, 2015

FDA approves Opdivo for metastatic squamous NSCLC

March 5, 2015

BMS gains option to license Prostvac from Bavarian Nordic

March 5, 2015

Addition of ipilimumab to Prostvac appears beneficial in treating prostate cancer

March 5, 2015

SBIR supports collaborative work in brain cancer between Nascent Biotech and Mapp Biopharmaceutical

March 4, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...